Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 6/20 | 0.42 |
| ▸ | PTPRF | P10586 | 9/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 9/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 3/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1662257 | 0.91 | PTPRF (0.42) | BCHEPTPRFPTPN2PTPN1KMT2A | |
| SCHEMBL12798742 | 0.89 | PTPRF (0.47) | BCHEPTPRFPTPN2PTPN1ACHE | |
| SCHEMBL1657906 | 0.89 | PTPRF (0.47) | BCHEPTPRFPTPN2PTPN1ACHE | |
| SCHEMBL1657894 | 0.82 | PTPRF (0.59) | BCHEPTPRFPTPN2PTPN1KMT2A | |
| SCHEMBL1657891 | 0.82 | PTPRF (0.59) | BCHEPTPRFPTPN2PTPN1KMT2A | |
| SCHEMBL1664516 | 0.81 | EGFR (0.45) | BCHEPTPRFPTPN2PTPN1KMT2A | |
| SCHEMBL1664515 | 0.81 | EGFR (0.45) | BCHEPTPRFPTPN2PTPN1KMT2A | |
| SCHEMBL12797573 | 0.80 | PTPRF (0.47) | BCHEPTPRFPTPN2PTPN1ACHE | |
| SCHEMBL1657084 | 0.80 | PTPRF (0.47) | BCHEPTPRFPTPN2PTPN1ACHE | |
| SCHEMBL1662173 | 0.73 | NAAA (0.44) | BCHEKMT2AACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011044138-A1 | LIPOIC ACID ACYLATED SALICYLATE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2011-04-14 | — | — | WO | disclosed |